Assessment of the low dose oral minoxidil in the post hair transplant treatment
Phase 4
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2024/03/063787
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All male patients who undergo hair transplantation following no response to conventional therapies
Patient consenting for study
Exclusion Criteria
Patient with history of cardio vascular diseases
Patients with chronic renal diseases
Patient with history of hypotension
Patient taking medications like aspirin, blood thinners and guanethidine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of oral minoxidil in post hair transplantation patients. <br/ ><br>To assess the safety and adverse effects associated low dose oral minoxidil. <br/ ><br>To evaluate patient satisfaction and subjective perceptions of treatment outcome.Timepoint: After 6 months
- Secondary Outcome Measures
Name Time Method Efficacy will be evaluated by hair counts, hair diameter measurements, anagen telogen ratio photographic assessment by trichoscanTimepoint: After 6 months